Search research articles
Contact Us
Filters
Showing results (621-630 of 764) with videos related to
Page
of 77
Sort By:
Muscle & Nerve
|
April 17, 2020
Paravertebral block for radiologically inserted gastrostomy tube placement in amyotrophic lateral sclerosis
Steven B Porter, Robert L McClain, Christopher B Robards, et al.
European Journal of Biochemistry
|
December 11, 1976
An assessment of some of the methods available for the determination of molecular weights of proteins as applied to aspartate aminotransferase from pig heart
B E Banks, S Doonan, M Flogel, et al.
European Journal of Haematology
|
November 25, 2014
Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study
Yesim Aydinok, John B Porter, Antonio Piga, et al.
British Journal of Haematology
|
September 1, 1993
Contrasting interspecies efficacy and toxicology of 1,2-diethyl-3-hydroxypyridin-4-one, CP94, relates to differing metabolism of the iron chelating site
J B Porter, R D Abeysinghe, K P Hoyes, et al.
The American Journal of Cardiology
|
June 1, 1985
Surgical treatment of accessory atrioventricular pathways and symptomatic tachycardia in children and young adults
D R Holmes, G K Danielson, B J Gersh, et al.
Pediatric Blood & Cancer
|
September 1, 2016
One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation
Adlette Inati, Mario Kahale, Nada Sbeiti, et al.
Lancet (London, England)
|
September 1, 2000
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
J L Rouleau, M A Pfeffer, D J Stewart, et al.
Haematologica
|
December 22, 2010
A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload
Hugh Young Rienhoff, Vip Viprakasit, Lay Tay, et al.
The New England Journal of Medicine
|
October 21, 1993
Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support
O W Press, J F Eary, F R Appelbaum, et al.
Annals of Hematology
|
October 23, 2012
Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy
J B Porter, M S Elalfy, A T Taher, et al.
Page
of 77
Search research articles
Search
Showing results (621-630 of 764) with videos related to
Sort By:
Page
of 77
Muscle & Nerve
|
April 17, 2020
Paravertebral block for radiologically inserted gastrostomy tube placement in amyotrophic lateral sclerosis
Steven B Porter, Robert L McClain, Christopher B Robards, et al.
European Journal of Biochemistry
|
December 11, 1976
An assessment of some of the methods available for the determination of molecular weights of proteins as applied to aspartate aminotransferase from pig heart
B E Banks, S Doonan, M Flogel, et al.
European Journal of Haematology
|
November 25, 2014
Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study
Yesim Aydinok, John B Porter, Antonio Piga, et al.
British Journal of Haematology
|
September 1, 1993
Contrasting interspecies efficacy and toxicology of 1,2-diethyl-3-hydroxypyridin-4-one, CP94, relates to differing metabolism of the iron chelating site
J B Porter, R D Abeysinghe, K P Hoyes, et al.
The American Journal of Cardiology
|
June 1, 1985
Surgical treatment of accessory atrioventricular pathways and symptomatic tachycardia in children and young adults
D R Holmes, G K Danielson, B J Gersh, et al.
Pediatric Blood & Cancer
|
September 1, 2016
One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation
Adlette Inati, Mario Kahale, Nada Sbeiti, et al.
Lancet (London, England)
|
September 1, 2000
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
J L Rouleau, M A Pfeffer, D J Stewart, et al.
Haematologica
|
December 22, 2010
A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload
Hugh Young Rienhoff, Vip Viprakasit, Lay Tay, et al.
The New England Journal of Medicine
|
October 21, 1993
Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support
O W Press, J F Eary, F R Appelbaum, et al.
Annals of Hematology
|
October 23, 2012
Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy
J B Porter, M S Elalfy, A T Taher, et al.
Page
of 77